Evaluation of Potential Therapies for a Mouse Model of Human Age-Related Macular Degeneration Caused by Delayed all-trans-Retinal Clearance
Authors:
- 1 October 2009
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 50 (10) , 4917-4925
Abstract
Purpose. Evaluate the efficacy of potential therapeutics in Rdh8 −/− Abca4 −/− mice, a rodent model of human age-related macular degeneration (AMD). methods. Therapeutic efficacy of several antioxidant agents (ascorbic acid, α-lipoic acid, α-tocopherol, Mn(III)-tetrakis(4-benzoic acid)-porphyrin, and butylated hydroxytoluene), an immunosuppressive agent with antivascular endothelial growth factor (VEGF) activity (sirolimus, also known as rapamycin), a retinoid cycle inhibitor (retinylamine), and an artificial chromophore (9-cis-retinyl acetate) were evaluated side by side in a recently described murine model of AMD, the Rdh8 −/− Abca4 −/− mouse. This animal exhibits a retinopathy caused by delayed all-trans-retinal clearance resulting from the absence of both ATP-binding cassette transporter 4 (Abca4) and retinol dehydrogenase 8 (Rdh8) activities. Drug efficacy was evaluated by retinal histologic analyses and electroretinograms (ERGs). results. All tested agents partially prevented atrophic changes in the Rdh8 −/− Abca4 −/− retina with retinylamine demonstrating the greatest efficacy. A significant reduction of complement deposition on Bruch’s membrane was observed in sirolimus-treated mice, although the severity of retinal degeneration was similar to that observed in antioxidant- and 9-cis-retinyl acetate–treated mice. Sirolimus treatment of 6-month-old Rdh8 −/− Abca4 −/− mice for 4 months prevented choroidal neovascularization without changing retinal VEGF levels. conclusions. Mechanism-based therapy with retinylamine markedly attenuated degenerative retinopathy in Rdh8 −/− Abca4 −/− mice. Further understanding of pathogenic mechanisms involved in AMD is needed to develop more effective therapeutics.Keywords
This publication has 39 references indexed in Scilit:
- Antioxidant or neurotrophic factor treatment preserves function in a mouse model of neovascularization-associated oxidative stressJournal of Clinical Investigation, 2009
- Noninvasive two-photon imaging reveals retinyl ester storage structures in the eyeJournal of Cell Biology, 2004
- An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient miceNature Medicine, 2003
- Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factorNature Medicine, 2002
- A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision LossArchives of Ophthalmology (1950), 2001
- Confronting Complexity: the Interlink of Phototransduction and Retinoid Metabolism in the Vertebrate RetinaProgress in Retinal and Eye Research, 2001
- TheRpe65Leu450Met Variation Increases Retinal Resistance Against Light-Induced Degeneration by Slowing Rhodopsin RegenerationJournal of Neuroscience, 2001
- Biochemical defects in ABCR protein variants associated with human retinopathiesNature Genetics, 2000
- Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindnessProceedings of the National Academy of Sciences, 2000
- A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture.1999